Cargando…

CYP2C19 polymorphisms and lipoproteins associated with clopidogrel resistance in children with Kawasaki disease in China: A prospective study

BACKGROUND: CYP2C19 genetic variation and clinical factors have been proved to be related with clopidogrel resistance (CR) in adults, while the presence of CR in children with Kawasaki disease (KD) was seldom reported. Our objective was to evaluate KD patients’ response to clopidogrel treatment and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Mingming, Meng, Li, Chen, Yeshi, Li, Xiaohui, Shi, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441694/ https://www.ncbi.nlm.nih.gov/pubmed/36072880 http://dx.doi.org/10.3389/fcvm.2022.925518

Ejemplares similares

Analysis of CYP2C19 gene polymorphism and influencing factors of pharmacological response of clopidogrel in patients with cerebral infarction in Zhejiang, China
por: Mo, Yijun, et al.
Publicado: (2023)

Association between Rab31/rs9965664 polymorphism and immunoglobulin therapy resistance in patients with Kawasaki disease
por: Yu, Hongyan, et al.
Publicado: (2022)

Establishment and Validation of a Multivariate Predictive Scoring Model for Intravenous Immunoglobulin-Resistant Kawasaki Disease: A Study of Children From Two Centers in China
por: Li, Changjian, et al.
Publicado: (2022)

Sterile Pyuria in Kawasaki Disease: A Large Prospective Cohort Study
por: Liu, Xiaoliang, et al.
Publicado: (2022)

Analysis of CYP2C19 genetic variants with ischaemic events in UK patients prescribed clopidogrel in primary care: a retrospective cohort study
por: Pilling, Luke C, et al.
Publicado: (2021)

Association of CYP2C19 Polymorphism with Clopidogrel Resistance in Patients with Acute Coronary Syndrome in China
por: Su, Qiang, et al.
Publicado: (2019)

Clinical Features in Children With Kawasaki Disease Shock Syndrome: A Systematic Review and Meta-Analysis
por: Zheng, Zhimin, et al.
Publicado: (2021)

CYP2C19 loss-of-function alleles predicts clinical outcomes in East Asian patients with acute myocardial infarction undergoing percutaneous coronary intervention and stenting receiving clopidogrel
por: Chen, Yu-Wei, et al.
Publicado: (2022)

Predictive Value of the Systemic Immune-Inflammation Index for Intravenous Immunoglobulin Resistance and Cardiovascular Complications in Kawasaki Disease
por: Liu, Xiaoliang, et al.
Publicado: (2021)

Low-dose and standard-dose ticagrelor compared with clopidogrel in patients with acute coronary syndromes: A cohort study from china
por: Peng, Wenxing, et al.
Publicado: (2022)

A novel model for predicting intravenous immunoglobulin-resistance in Kawasaki disease: a large cohort study
por: Wang, Shuhui, et al.
Publicado: (2023)

Antibodies and Immunity During Kawasaki Disease
por: Hicar, Mark Daniel
Publicado: (2020)

Similar Inflammatory Biomarkers Reflect Different Platelet Reactivity in Percutaneous Coronary Intervention Patients Treated With Clopidogrel: A Large-Sample Study From China
por: Li, Jiawen, et al.
Publicado: (2021)

Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis
por: Qiu, Yu, et al.
Publicado: (2022)

Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients
por: Zhuo, Zhong-ling, et al.
Publicado: (2018)

Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in Acute Coronary Syndrome: A Comprehensive Meta-Analysis
por: Sun, Mengyi, et al.
Publicado: (2022)

Development of prognostic nomogram model to predict syncope recurrence in children with vasovagal syncope
por: Sun, Rui, et al.
Publicado: (2023)

Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
por: Xi, Ziwei, et al.
Publicado: (2021)

Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study
por: Lee, Meng, et al.
Publicado: (2014)

Comparing the effectiveness and safety of dual antiplatelet with ticagrelor or clopidogrel in elderly Asian patients with acute myocardial infraction
por: Yeh, Jong-Shiuan, et al.
Publicado: (2023)

Ticagrelor vs. clopidogrel for coronary microvascular dysfunction in patients with STEMI: a meta-analysis of randomized controlled trials
por: Li, Yike, et al.
Publicado: (2023)

An Update on Cardiovascular Risk Factors After Kawasaki Disease
por: Zeng, Yuan-Yuan, et al.
Publicado: (2021)

Comment on “Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients”
por: Wang, Bin, et al.
Publicado: (2018)

CYP2C19 metabolizer phenotypes may affect the efficacy of statins on lowering small dense low-density lipoprotein cholesterol of patients with coronary artery disease
por: Dai, Ruozhu, et al.
Publicado: (2022)

The role of clopidogrel resistance-related genetic and epigenetic factors in major adverse cardiovascular events among patients with acute coronary syndrome after percutaneous coronary intervention
por: Giantini, Astuti, et al.
Publicado: (2023)

Echocardiography and laboratory outcomes of COVID-19 in children with a history of Kawasaki disease: a preliminary observation
por: Guo, Mindy Ming-Huey, et al.
Publicado: (2023)

Prediction Model Risk-of-Bias Assessment Tool for coronary artery lesions in Kawasaki disease
por: Huang, Hongbiao, et al.
Publicado: (2022)

The Effect of Ticagrelor on Endothelial Function Compared to Prasugrel, Clopidogrel, and Placebo: A Systematic Review and Meta-Analysis
por: Guan, Baoyi, et al.
Publicado: (2022)

Cumulative non-high-density lipoprotein cholesterol burden and risk of atherosclerotic cardiovascular disease: a prospective community-based study
por: Guan, Xu-Min, et al.
Publicado: (2023)

Association of the Monocyte–to–High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy
por: Tang, Xixiang, et al.
Publicado: (2021)

Ticagrelor vs. Clopidogrel in Older Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From a Real-World Registry
por: Zhang, Yunnan, et al.
Publicado: (2022)

The role of red blood cell distribution width in predicting coronary artery lesions in pediatric patients with kawasaki disease
por: Cai, Jianghui, et al.
Publicado: (2023)

Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China
por: Chang, Rong, et al.
Publicado: (2022)

Lymphocyte to High-Density Lipoprotein Ratio but Not Platelet to Lymphocyte Ratio Effectively Predicts Metabolic Syndrome Among Subjects From Rural China
por: Yu, Shasha, et al.
Publicado: (2021)

Association with CYP2C19 polymorphisms and Clopidogrel in treatment of elderly stroke patients
por: Li, Changqing, et al.
Publicado: (2021)

The association between higher FFAs and high residual platelet reactivity among CAD patients receiving clopidogrel therapy
por: Zhao, Zehao, et al.
Publicado: (2023)

Tanshinone IIA Has a Potential Therapeutic Effect on Kawasaki Disease and Suppresses Megakaryocytes in Rabbits With Immune Vasculitis
por: Chen, Hui, et al.
Publicado: (2022)

Endothelial Transcytosis of Lipoproteins in Atherosclerosis
por: Zhang, Xinbo, et al.
Publicado: (2018)

Pinocytotic engulfment of lipoproteins by macrophages
por: Miyazaki, Takuro
Publicado: (2022)

Risk factors and coronary artery outcomes of coronary artery aneurysms differing in size and emergence time in children with Kawasaki disease
por: Liu, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_300ngkd3jiko1qg3c21bv2839h